Synchron's Catheter-Based BCI Advantage

Synchron is turning brain computer interfaces from a rare neurosurgery program into a procedure that can fit inside an existing hospital workflow. Its Stentrode is delivered through the jugular vein with standard catheter lab equipment, in about two hours, then paired with an implanted chest unit and external software, which means adoption depends more on hospitals adding a new device than building a new surgical stack.

• The practical advantage is who can do the case. Synchron is built around interventional radiology and catheter skills already used for stents, while Neuralink pairs its implant with skull opening and robotic thread insertion, which narrows the set of facilities and specialists that can offer the procedure.
  1 sacra 2 synchron 3 sacra
• That lower friction comes with a product tradeoff. Synchron uses a 16 electrode array in a blood vessel near the motor cortex and supports basic cursor control, texting, and smart device use, while Neuralink and Precision are pursuing much higher channel counts through direct cranial access to capture richer signals.
  1 sacra 2 synchron 3 sacra 4 precisionneuro
• The business implication is simpler rollout. Synchron prices the system around a $60,000 device sale plus software and support, and because patients are typically discharged within 1 to 2 days after a standard catheter lab procedure, the economics look closer to other hospital implant programs than to a bespoke neurosurgical platform.
  1 sacra 2 synchron

The next phase of competition is likely to split the market by procedure burden versus signal performance. Synchron is well positioned where hospitals want the easiest path to offering thought driven device control, while competitors using direct brain access will keep pushing higher bandwidth for patients and applications that justify more complex surgery.